RE:RE:RE:RE:RE:RE:Level ll QuoteIf they intend to tell us if they have applied for, or will, that BTD, next week is a good time for that. If so, I suspect that a few more patients have been checked with CR. If it drags on, well maybe they weren't CR. But who knows. Just speculating. Maybe they will not even tell us when they apply. Anyway, the next update should have a lot of data in it. 6 months for a bunch of people and half a dozen or so fresh ones at 3 months. Hopefully, old tricks of dropping to the twenties will not be happening in the mean time.
When a GBM phase 1 trial starts, how many people would be ideal? A very small trial or as many patients as possible? The costs will of course increase the more people who are in it but if they have the goods in the end, that should not matter much one would think.
Let's break 40 cents in Q1!